Media partners: GE and Valneva boost for vaccines made using EB66 cell line
GE Healthcare and Valneva have developed a cell culture media they say reduced batch variability when producing viruses from the EB66 cell line.
Archives for November 8, 2016
Rentschler ups capacity again, with second 2,000L single-use bioreactor
Biologics CMO Rentschler has increased its single-use capacity by 50%, just weeks after opening a stainless steel facility at its site in Germany.
Repligen: resin recovery feature a ‘differentiator’ in chromatography space
A resin recovery feature being added to its larger prefilled chromatography columns offers an ‘insurance policy’ for drugmakers, says Repligen.
Mylan targets US Herceptin market with FDA biosimilar submission
A Herceptin (trastuzumab) biosimilar developed by Mylan and Biocon has been submitted to the US FDA.